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INT ROD UCT ION
Type 1 diabetes (T1D) is an autoimmune disease character-
ized by T cell–mediated destruction of insulin-producing 
pancreatic β cells (Bluestone et al., 2010). Interacting genetic 
and environmental factors eventually lead to the loss of func-
tional β cell mass and hyperglycemia (Bluestone et al., 2010; 
Polychronakos and Li, 2011; Nielsen et al., 2014). The discor-
dant diabetes incidence in monozygotic twins (<50% devel-
oped T1D) strongly suggests that nongenetically determined 
factors regulate T1D development (Kaprio et al., 1992). Re-
cent studies in mouse models and humans have shown that 
gut microbiota play an important role in disease development.
We previously showed that commensal bacteria modi-
fied diabetes development in nonobese diabetic (NOD) mice 
via myeloid differentiation primary response 88 (MyD88). 
Specific pathogen-free MyD88-deficient (MyD88−/−) NOD 
mice were protected from T1D development, whereas germ-
free MyD88−/−NOD mice developed normal diabetes (Wen 
et al., 2008). Gender bias in T1D in NOD mice is influenced 
by microbiota (Markle et al., 2013; Yurkovetskiy et al., 2013). 
Studies in humans also indicate that the gut microbiome plays 
an important role in T1D development. Gut microbial com-
munities in high-risk children are characterized as less diverse, 
distinct from those of healthy controls (Brown et al., 2011; 
Kostic et al., 2015). Furthermore, a low abundance of lactate- 
and butyrate-producing bacteria, reduced Bifidobacterium 
species, and increased bacteria of the Bacteroides genus were 
found in islet autoantibody–positive children (de Goffau et 
al., 2013). Individuals with islet autoantibodies, sero-negative 
first-degree relatives, and new-onset patients had different 
abundances of Lactobacillus and Staphylococcus (both Fir-
micutes) compared with healthy control subjects (Alkanani 
et al., 2015). Thus, altered gut microbiota are associated with 
β cell autoimmunity in humans at risk of developing T1D, 
underscoring a role for gut microbiota in the pathogenesis of 
antiislet cell autoimmunity and T1D development.
CD8+ T cells play an important role in the development 
of T1D in both NOD mice and humans (Wong et al., 1999, 
2009; Liblau et al., 2002; Lieberman et al., 2003; Tsai et al., 
2008). CD8+ T cells predominate in islet infiltrates in patients 
with T1D (Willcox et al., 2009), and islet autoantigen–spe-
cific CD8+ T cell clones were generated from the peripheral 
blood of T1D patients (Peakman et al., 1994; Unger et al., 
2007; Skowera et al., 2008). Other studies have demonstrated 
heightened expression of MHC class I and CD8+ T cells in the 
islets of patients with T1D (Foulis et al., 1987; Coppieters et 
al., 2012; Pugliese et al., 2014; Rodriguez-Calvo et al., 2015). 
However, there is a substantial gap in our knowledge of how 
islet autoimmunity mediated by CD8+ T cells is shaped by in-
nate immunity and the gut microbiota. To investigate the link 
of innate immunity and gut microbiota to CD8+ T cells in 
T1D development, we generated MyD88−/−NOD mice car-
Both animal model and human studies indicate that commensal bacteria may modify type 1 diabetes (T1D) development. 
However, the underlying mechanisms by which gut microbes could trigger or protect from diabetes are not fully understood, 
especially the interaction of commensal bacteria with pathogenic CD8 T cells. In this study, using islet-specific glucose-6-phos-
phatase catalytic subunit–related protein (IGRP)–reactive CD8 T cell receptor NY8.3 transgenic nonobese diabetic mice, we 
demonstrated that MyD88 strongly modulates CD8+ T cell–mediated T1D development via the gut microbiota. Some microbial 
protein peptides share significant homology with IGRP. Both the microbial peptide mimic of Fusobacteria and the bacteria 
directly activate IGRP-specific NY8.3 T cells and promote diabetes development. Thus, we provide evidence of molecular mim-
icry between microbial antigens and an islet autoantigen and a novel mechanism by which the diabetogenicity of CD8+ T cells 
can be regulated by innate immunity and the gut microbiota.
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rying diabetogenic CD8+ TCR NY8.3, specific for islet-spe-
cific glucose-6-phosphatase catalytic subunit–related protein 
(IGRP; Verdaguer et al., 1997; Lieberman et al., 2003). To our 
surprise, the mice developed highly accelerated diabetes with 
altered gut microbiota enriched in Fusobacteria that express a 
magnesium transporter (Mgt) encompassing a microbial pep-
tide mimic of IGRP. The mimic peptide directly activated 
IGRP-specific CD8+ T cells and, importantly, induced ro-
bust diabetes in vivo. Supercolonization of the mice with this 
strain of bacteria accelerated diabetes in NY8.3NOD mice. 
Lastly, increased fecal Fusobacteria were also associated with 
diabetes progression in NOD mice. Therefore, our study pro-
vides direct evidence that molecular mimicry by microbial 
peptides of islet autoantigen contributes to T1D.
RES ULTS
Accelerated diabetes in MyD88−/−NY8.3NOD mice is 
MyD88 dependent, IGRP reactive, and TCR specific
To better understand the interplay among innate immunity, 
gut microbes, and diabetogenic CD8+ T cells, we generated 
several lines of TLR-deficient (TLR−/−) and MyD88−/− 
NY8.3NOD mice. TLR2−/− and male TLR9−/−NY8.3 mice 
had significantly delayed diabetes onset (Fig.  1, A and D), 
whereas TLR4−/−, TLR5−/−, and female TLR9−/−NY8.3 
mice were not affected by the loss of these TLRs (Fig.  1, 
B–D). In contrast, MyD88−/−NY8.3 mice (both sexes) de-
veloped markedly accelerated diabetes (Fig.  1  E). This 
also contrasts with the protected phenotype in polyclonal 
MyD88−/−NOD mice in specific pathogen-free conditions 
(Wen et al., 2008). Interestingly, there was no gender dif-
ference in diabetes incidence in either WT NY8.3NOD 
or MyD88−/−NY8.3NOD mice (not depicted). Collec-
tively, our data suggest that the accelerated diabetes in 
MyD88−/−NY8.3NOD mice is MyD88 dependent.
CD8+ T cells are more activated in MyD88−/−NY8.3 mice
We next examined the phenotype and function of NY8.3 
CD8+ T cells. MyD88 deficiency does not affect thymic se-
lection of NY8.3 T cells (Fig. 2 A); however, the number of 
splenic CD8+ T cells was lower in MyD88−/−NY8.3NOD 
mice compared with the NY8.3NOD mice (Fig.  2  B). 
There were no differences in the number of CD8+ T cells 
in pancreatic LN or mesenteric LN (MLN; not depicted). 
In contrast, we found more CD8+ T cells in islet infil-
trates of MyD88−/−NY8.3NOD mice compared with WT 
NY8.3NOD mice (Fig. 2 C). Furthermore, there was no dif-
ference in Foxp3+CD4+ T regulatory cells in the lymphoid 
tissues examined (Fig. 2 D), but there were more activated 
(CD69+) and memory/effector (CD62Llow/CD44high) NY8.3 
CD8+ T cells in MyD88−/− hosts (Fig. 3, A and B). CD8+ T 
cells from MyD88−/−NY8.3NOD mice also showed stronger 
responses to their native autoantigen, IGRP206–214 peptide, and 
expressed more granzyme B upon anti-CD3 stimulation in 
vitro, compared with WT mice (Fig. 3, C and D). Importantly, 
they induced more aggressive diabetes in vivo (Fig.  3  E). 
These data demonstrated that MyD88 deficiency resulted in 
stronger activation of CD8+ T cells in NY8.3NOD mice.
MyD88 deficiency changes gut microbiota composition in 
NY8.3 mice and modifies diabetes development
We tested whether MyD88 deficiency also affected the 
composition of gut microbiota in MyD88−/−NY8.3NOD 
mice as in polyclonal NOD mice (Wen et al., 2008) by 
16S rRNA pyrosequencing of the fecal samples from 
MyD88−/− and WT NY8.3NOD mice. MyD88 defi-
ciency indeed altered gut microbiota composition (Fig.  4, 
A–C) with a much greater α and β diversity in the bacte-
rial community of MyD88−/−NY8.3NOD mice com-
pared with WT NY8.3NOD mice (Fig.  4, D and E). 
Actinobacteria, Bacteroidetes, and Proteobacteria were in-
creased, and Firmicutes was reduced at the phylum level, 
whereas Lactobacillus was significantly less abundant at 
the genus level in MyD88−/−NY8.3NOD mice compared 
with WT NY8.3NOD mice.
Next, we quantified the levels of antimicrobial pep-
tides, which affect gut bacterial growth, in the intestines. 
Expression of Reg3β, Reg3γ, RELMβ, and C-reactive pro-
tein–ductin were reduced in MyD88−/−NY8.3NOD mice 
(Fig. 5, A and B), which may have contributed to the altered 
gut microbiome in MyD88−/−NY8.3NOD mice, affect-
ing diabetes development.
Manipulation of gut microbiota alters diabetes development 
in MyD88−/−NY8.3NOD mice
To test whether the altered gut microbiota in 
MyD88−/−NY8.3NOD mice was responsible for the accel-
erated diabetes, we cohoused the MyD88−/−NY8.3NOD 
mice with WT NOD mice. Remarkably, ∼80% of 
MyD88−/−NY8.3NOD mice were completely protected 
from diabetes development when cohoused with age- and 
sex-matched WT NOD mice (Fig. 6 A). This cohousing nei-
ther changed the activation of CD4+ or CD8+ T cells nor 
affected the insulitis in WT NOD mice (not depicted), and 
there was no modulation of the diabetes development in WT 
NOD mice (not depicted). This implies that the WT micro-
biota had a dominant effect on the MyD88−/−NY8.3NOD 
mice rather than vice versa. As a control, we also cohoused 
WT NY8.3NOD mice with WT NOD mice, which did 
not affect diabetes incidence in WT NY8.3NOD (not de-
picted). To test whether the protected phenotype was hor-
izontally transferable to a second host, we performed fecal 
transfer by orally gavaging the fecal suspension from diabe-
tes-free cohoused MyD88−/−NY8.3NOD mice to another 
set of naïve MyD88−/−NY8.3NOD mice. Interestingly, 
oral transfer (OT) of gut microbes from diabetes-protected 
MyD88−/−NY8.3NOD donors conferred even greater pro-
tection against diabetes, accompanied by a marked reduction 
in insulitis (Fig. 6, B and C) and an alteration of gut microbi-
ota α-diversity, β-diversity, or composition ascertained by 16S 
rRNA pyrosequencing (Fig. 6, D–G). Interestingly, in the mice 
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Figure 1. MyD88 deficiency has different ef-
fect on diabetes development. (A–E) Individual TLR- or 
MyD88−/−NY8.3NOD mice were generated by breeding dif-
ferent TLR−/− or MyD88−/−NOD mice with NY8.3 NOD mice. 
Diabetes development was observed, and data were pooled 
from at least five independent experiments. (A) TLR2−/−NY8.3. 
(B) TLR4−/−NY8.3. (C) TLR5−/−NY8.3. (D) TLR9−/−NY8.3. (E) 
MyD88−/−NY8.3. Wilcoxon test for survival was used for anal-
ysis of diabetes incidence. *, P < 0.05; **, P < 0.01; ***, P < 
0.001. F, female. M, male.
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that were protected from diabetes by cohousing or fecal trans-
fer, there was a clear reduction in Bacteroidetes and an increase 
of Firmicutes at the phylum level of the microbiota commu-
nity in MyD88−/−NY8.3 mice compared with the control 
counterparts (Fig. 6 F). To investigate whether the protected 
phenotype was vertically transferable to the next generation, 
we used horizontally protected MyD88−/−NY8.3NOD mice 
as breeders and observed diabetes development in their prog-
eny. Strikingly, the disease protection was indeed vertically 
transferable (Fig.  6  H). Collectively, our data suggest that 
MyD88 deficiency in NY8.3NOD mice results in dysbiosis 
of the gut microbiota, leading to accelerated diabetes. How-
ever, cohousing completely reversed the diabetic phenotype, 
and importantly, diabetes protection was transferable to new 
hosts and to the next generation.
Microbial mimic peptides can stimulate diabetogenic CD8+  
T cells in vitro and induce diabetes in vivo
To probe the mechanism by which dysbiosis of gut com-
mensals, in the absence of MyD88, leads to highly accelerated 
Figure 2. MyD88 deficiency has no effect on T cell development in thymus and regulatory T cell differentiation. (A) Thymocytes from 6–7-wk-
old MyD88−/−NY8.3NOD and WT NY8.3NOD mice (sex matched) were stained with fluorochrome-conjugated anti-TCRβ, anti-CD4, and anti-CD8 antibodies. 
n = 8–10 mice/group from two independent experiments. (B) CD8+ T cells in the spleen of MyD88−/−NY8.3NOD mice. The experiment was performed in 
three independent experiments, and two-tailed Mann-Whitney test was used for statistical analysis. *, P < 0.05. (C) The absolute number of infiltrated 
CD4+ and CD8+ T cells in the islets of MyD88−/−NY8.3NOD mice after gating with TCRβ-positive cells is shown. The data were from two independent ex-
periments. (D) Natural regulatory T cells in MyD88−/−NY8.3NOD mice. n ≥ 6 mice/group/experiment from two independent experiments. PLN, pancreatic 
LN. Data are mean ± SEM. 
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diabetes development in NY8.3NOD mice, we hypothe-
sized that gut bacterial products may activate NY8.3 CD8+ T 
cells. We compared the IGRP206–214 peptide sequence against 
bacterial protein sequences in the nonredundant protein se-
quence database and found several peptides from oral or gut 
bacteria that share strong homology with IGRP206–214, the na-
tive autoantigen of NY8.3 CD8+ T cells (Table 1). Three of 
these IGRP mimic peptides, designated as W15944, W15946, 
and W15948, activated NY8.3 CD8+ T cells with a compara-
ble potency with IGRP native peptide using: (a) proliferation 
of NY8.3 CD8+ T cells (Fig.  7  A), (b) IFN-γ production, 
and (c) induction of granzyme B (Fig.  7  B). Furthermore, 
all the responses were restricted by MHC class I–Kd (Fig. 7, 
C and D). Importantly, the microbial mimic peptides, which 
activated NY8.3 CD8+ T cells, induced these NY8.3 CD8+ 
T cells to rapidly transfer diabetes in vivo (Fig.  7  E). The 
peptide mimic W15945 was not stimulated NY8.3 CD8+ 
T cells in vitro (Fig.  7  A) and did not induce diabetes in 
vivo (not depicted). Comparatively, W15944 stimulated the 
NY8.3 T cells most strongly both in vitro and in vivo (Fig. 7, 
A, B, and E). When compared with IGRP206–214, W15944 
induced stronger CTL function of NY8.3 CD8+ T cells in 
vitro and similar diabetogenicity in vivo (Fig.  7, F and G). 
W15944-, W15946-, and W15948-activated CD8+ T cells 
from MyD88−/−NY8.3NOD mice all induced significantly 
higher diabetes incidence in irradiated young NOD mice 
compared with their WT counterparts that were activated in 
parallel (Fig. 7, H–J). 100% of NOD recipients developed di-
abetes by day 6 after adoptive transfer of W15944-activated 
MyD88−/−NY8.3 CD8+ T cells (Fig. 7 J). Furthermore, im-
munization with W15944 induced significantly accelerated 
diabetes in WT NY8.3NOD mice compared with IGRP206–
214 or CpG alone (Fig. 7 K). To further test that the micro-
bial peptides specifically stimulated NY8.3 CD8+ T cells, we 
stimulated insulin-reactive G9 CD8+ T cells with the mimic 
peptides. As expected, all the microbial peptides tested failed 
to activate G9 CD8+ T cells that are specific for insulin B15-
23 (Wong et al., 1996, 2009), suggesting the specificity of the 
microbial peptides to IGRP (Fig. 7 L). Collectively, our data 
strongly suggest that microbial antigen mimics can act as ag-
onists that not only activate islet antigen–specific pathogenic 
CD8+ T cells in vitro, but also induce robust diabetes in vivo.
Increased abundance of Fusobacteria and Leptotrichia 
goodfellowii is associated with accelerated diabetes
The microbial peptide mimic W15944 derives from an Mgt 
(GenePept accession no. WP_006806773) of L. goodfellowii, 
a member of the phylum Fusobacteria (gram-negative an-
Figure 3. MyD88 deficiency promotes highly pathogenic NY8.3 CD8+ T cells. (A) CD69 expressing CD8+ T cells in MyD88−/−NY8.3 mice. n = 4 mice/
group/experiment from more than three experiments. PLN, pancreatic LN. (B) Mean fluorescence intensity (MFI) of CD62L and CD44 of gated splenic CD8+ 
T cells from MyD88−/−NY8.3 and WT NY8.3 mice was determined by flow cytometric analysis from three independent experiments. (C) Splenocytes from 
MyD88−/−NY8.3 or WT NY8.3 mice were tested upon antigen stimulation by [3H]thymidine incorporation assay. n = 3 mice/group/experiment from more 
than three experiments. Two-way ANO VA was used for the comparison with Bonferroni correction. (D) Granzyme B–expressing CD8+ T cells in the spleen 
of MyD88−/−NY8.3NOD mice stimulated by anti-CD3 and anti-CD28 followed by ICC staining. Data are from five independent experiments. (E) Diabetes 
incidence after adoptive transfer. 106 purified IGRP-stimulated splenic CD8+ T cells were injected i.v. into recipient NOD mice in two independent experi-
ments. Wilcoxon test for survival was used for analysis. (A, B, and D) Two-tailed Student’s t test was used for analysis. Data are mean ± SEM. *, P < 0.05; **, 
P < 0.01; ***, P < 0.001.
o
n
 N
ovem
ber 21, 2016
D
ow
nloaded from
 
Published September 12, 2016
Microbial antigens and islet-reactive CD8 T cells | Tai et al.2134
aerobe), a human and NOD mouse oral commensal (not 
depicted). Fusobacteria are associated with inflammatory 
disorders including skin ulcers (Legaria et al., 2005) and in-
flammatory bowel diseases (Ohkusa et al., 2003; Strauss et 
al., 2011). We found that the Fusobacteria represent <0.1% 
of sequencing reads of fecal samples of MyD88−/− and WT 
NY8.3NOD mice. To quantify the presence of Fusobac-
teria or L. goodfellowii, we performed quantitative PCR 
(qPCR) with specific primers using bacterial DNA from 
fecal and oral samples of prediabetic MyD88−/−NY8.3NOD 
and sex- and age-matched WT NY8.3NOD mice. 
MyD88−/−NY8.3NOD mice harbored significantly more 
Fusobacteria in both fecal and oral samples and more L. good-
fellowii in oral samples (Fig. 8 A). Interestingly, a significant 
reduction of the abundance of Fusobacteria was observed in 
the fecal samples of the protected cohoused or orally trans-
ferred MyD88−/−NY8.3NOD mice compared with control 
mice, indicating that the reduced abundance of Fusobacteria 
could be associated with the reduced diabetes incidence in 
these mice (Fig. 8 B).
Next, we investigated whether the abundance of Fuso-
bacteria is associated with diabetes development in WT NOD 
Figure 4. MyD88 deficiency results in distinct gut microbiota in NY8.3NOD mice. (A–C) Fecal samples from WT NY8.3NOD and MyD88−/−NY8.3NOD 
mice were used for taxonomic analysis by 16S rRNA sequencing. The taxonomic compositions of gut bacteria were shown in phylum (left, pies; right, 
bars; A) family (B), and genus (C). (A and C) Two-way ANO VA with Bonferroni correction was used. (D) α-Diversity of gut microbiota of WT NY8.3NOD and 
MyD88−/−NY8.3NOD mice was shown by Shannon evenness and Chao richness. Two-tailed Student’s t test was used. (E) β-Diversity, shown by principal 
component analysis (PCoA; unweighted) of taxonomic families of gut microbiota. ANO SIM was used for statistical analysis. Two independent sequencing 
experiments with different cohorts were performed, and one representative (A, B, C, and E) and the pooled data (D) are shown. Data are mean ± SEM. 
*, P < 0.05; ***, P < 0.001. M, male.
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mice. We found a significantly higher abundance of Fusobac-
teria in the fecal samples of new-onset diabetic compared 
with age-matched nondiabetic female NOD mice (Fig. 8 C). 
Furthermore, we collected serial fecal samples from 6-wk-old 
female NOD mice until diabetes onset. Of note, we observed 
a significant increase in the abundance of Fusobacteria in 
the fecal samples from prediabetic (13–16 wk old) compared 
with young mice (no insulitis 6 wk or mid-insulitis 10 wk), 
indicating a possible role of Fusobacteria in diabetes devel-
opment, as these mice all became diabetic later (Fig.  8 D). 
Collectively, these data suggest a possible association between 
the abundance of Fusobacteria and diabetes development.
L. goodfellowii activates NY8.3 CD8+ T cells in vitro and 
accelerates diabetes in WT NY8.3NOD mice in vivo
As the peptide mimic W15944 exerted pathogenic effects by 
strongly stimulating NY8.3 CD8+ T cells in vitro and induc-
ing rapid diabetes in vivo, we tested whether APCs can process 
and present W15944 from L. goodfellowii. First, we stimulated 
splenocytes from MyD88−/− or WT NY8.3NOD mice with 
the whole cell lysates of L. goodfellowii. Bacteroides thetaio-
taomicron (B. theta), also a gram-negative anaerobe, was used 
as a control. Bacterial lysates of L. goodfellowii induced signifi-
cantly higher expression of IFN-γ in MyD88−/−NY8.3NOD 
CD8+ T cells compared with WT NY8.3NOD CD8+ T cells 
(Fig. 9 A). This was confirmed using purified BMDCs or en-
riched APCs from spleens and gut-associated lymphoid tissue 
(GALT), including MLN and Peyer’s patches (PP), of NOD 
mice (not depicted). Second, using a cell-free Escherichia coli 
S30 extraction system to express recombinant Mgt (rMgt) 
protein, we stimulated NY8.3 CD8+ T cells and induced a 
significantly larger amount of MIP-1β (early CD8+ T cell ac-
tivation indicator) production compared with the negative 
control, E. coli S30 with an empty vector (Fig. 9 B). We also 
used truncated rMgt protein as an antigen in the stimula-
tion assay. CD8+ T cells from both WT NY8.3 NOD and 
MyD88−/−NY8.3NOD mice responded strongly to the an-
tigen presented by purified NOD splenic APCs (Fig. 9 C). 
Third, we tested the capacity of GALT APCs, in vitro pulsed 
with L. goodfellowii, to process and present the IGRP mimic 
in the absence of exogenous antigen. L. goodfellowii–pulsed 
GALT APC induced significantly higher expression of IFN-γ 
and TNF by NY8.3 CD8+ T cells than those pulsed with 
B. theta (Fig. 9 D). Fourth, we supercolonized 2–3-mo-old 
female NOD mice by oral gavage with either L. goodfellowii 
or B. theta daily for five consecutive days. Splenic or GALT 
APCs from the L. goodfellowii–gavaged NOD mice readily 
induced a significantly larger amount of MIP-1β and a higher 
expression of IFN-γ in NY8.3 CD8+ T cells compared with 
the splenic or GALT APCs from B. theta–treated mice (Fig. 9, 
E and F). To further confirm the specific recognition of L. 
goodfellowii by NY8.3 CD8+ T cells, we tested two more 
bacterial strains, Bacteroides dorei and Lactobacillus reuteri, 
in addition to B. theta. All the strains tested, except L. good-
fellowii, failed to stimulate NY8.3 CD8+ T cells (Fig. 9 G). 
Finally, we orally gavaged the young WT NY8.3NOD mice 
with L. goodfellowii or B. theta to test the diabetogenicity 
directly. The supercolonization of L. goodfellowii signifi-
cantly accelerated diabetes development in WT NY8.3NOD 
mice compared with B. theta–colonized mice or untreated 
WT NY8.3NOD mice (Fig.  9  H). Collectively, these data 
demonstrated that L. goodfellowii, as well as the purified Mgt 
protein, can be processed by splenic or GALT APCs from 
NOD mice to stimulate the NY8.3 cells. Most importantly, 
the bacteria can trigger early onset of diabetes.
DIS CUS SION
In this study, we present evidence that a transporter protein 
peptide from a strain of Fusobacteria can be processed and 
presented by gut-associated antigen-presenting cells and stim-
Figure 5. Reduced intestinal antimicro-
bial peptide expression in NY8.3NOD mice 
in the absence of MyD88. (A and B) Gene 
expression for the intestinal antimicrobial 
peptides. Fragments (∼3 cm) of the small in-
testines from ileum and large intestine ad-
jacent to the cecum were harvested from 
6–7-wk-old sex-matched WT NY8.3NOD and 
MyD88−/−NY8.3NOD mice. After intensive 
washing with sterile PBS, RNA was extracted 
from the fragments using TRIzol, followed by 
reverse transcription. qPCR was performed to 
determine the mRNA levels of antimicrobial 
peptides, which were normalized to the house-
keeping gene GAP DH. (A) Small intestine. (B) 
Large intestine. Five to eight mice/group from 
two independent experiments are shown. One-
tailed Mann-Whitney test was used for statis-
tical analysis. Data are shown as mean ± SEM. 
*, P < 0.05; **, P < 0.01. CRP, C-reactive protein.
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Figure 6. Manipulation of gut microbiota protects from diabetes development in MyD88−/−NY8.3 mice. (A) Diabetes incidence in MyD88−/−NY8.3NOD 
mice after 4-wk-old MyD88−/−NY8.3NOD mice were cohoused with an equal number and age- and sex-matched NOD mice. F, female; M, male. (B) Dia-
betes development of MyD88−/−NY8.3NOD mice after fecal OT. The fresh gut bacteria (∼108–109 culturable bacteria/mouse) from diabetes-free cohoused 
MyD88−/−NY8.3 mice (from A) were fed orally to sex-matched 4-wk-old naive MyD88−/−NY8.3NOD mice. (C) Insulitis of MyD88−/−NY8.3NOD mice after 
cohousing with WT NOD mice or OT (from A and B). More than120 islets from five to six treated mice/group were examined. Representative pancreatic 
sections are shown on the left, and the summary of the insulitis scores is shown on the right. χ2 test was used for analysis. (D) α-Diversity of gut microbiota 
is shown by Chao richness. Fecal samples from the control, cohoused, and OT MyD88−/−NY8.3NOD mice were used for taxonomic analysis by 16S rRNA 
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ulate IGRP-reactive CD8 T cells to accelerate diabetes. These 
bacteria are increased in the gut microbiome in the absence of 
MyD88. Using IGRP-reactive NY8.3 TCR transgenic mice 
as a model, MyD88−/−NY8.3NOD mice developed highly 
accelerated diabetes. The gut microbiota play a critical role 
in the disease acceleration, confirmed by disease reduction 
when the gut microbiome are altered via cohousing or fecal 
transfer from nondiabetes-accelerated mice. Moreover, super-
colonization with the live bacteria or immunization with the 
microbial peptide in NY8.3 mice accelerated diabetes, and 
importantly, these bacteria also increase in polyclonal NOD 
mice during diabetes progression and at diabetes onset.
Although there are several studies showing gut com-
mensals influence autoimmunity, none have demonstrated di-
rect influence through stimulation of the autoreactive T cells 
in diabetes. Molecular mimicry has long been suggested as 
a pathogenic mechanism for the development of T1D, but 
to date, although demonstrated in some autoimmune dis-
eases, there has been no convincing direct evidence for T1D. 
To probe the mechanism, a defined setting is required. We 
used TCR transgenic mice that develop spontaneous dia-
betes, allowing us to study the known TCR clonotypes and 
the possible mimic agonists. The NY8.3 cells are highly pro-
miscuous as demonstrated by the initial difficulty of identi-
fying the autoantigen by the screening of a peptide library 
(Anderson et al., 1999), and indeed this is the case for many 
low-affinity autoreactive T cells (Wooldridge et al., 2012). 
This promiscuity of T cell antigen recognition makes it likely 
that more than one naturally occurring peptide product can 
stimulate the T cells, implying that the gut bacteria could be 
a particularly rich source of potential antigens. Several mi-
crobial peptides are highly homologous to islet autoantigen 
IGRP206–214, the ligand of NY8.3 TCR, and can stimulate the 
diabetogenic NY8.3 cells. One of these is from the Mgt pro-
tein of L. goodfellowii, a strain of Fusobacteria, enriched in 
the MyD88−/−NY8.3NOD mice. IGRP is a key target for 
diabetogenic CD8 T cells in both the NOD mouse as well 
as in humans (Lieberman et al., 2003; Jarchum et al., 2008; 
Ko et al., 2014). NY8.3-like CD8 T cells increase in NOD 
mice with increasing avidity for their target antigen along 
with the progression to diabetes development in unmanip-
ulated NOD mice (Amrani et al., 2000), and this coincides 
with the increase of fecal Fusobacteria in NOD mice shown 
in this study. To our knowledge, this is the first direct demon-
stration of a specific gut bacterium to stimulate a TCR that 
increases in avidity with time.
Previous studies have shown TCR cross-reactivity be-
tween MHC II–binding self-antigen and foreign peptides 
including microbial products, which could cause autoimmu-
nity by stimulating autoreactive T cells (Birnbaum et al., 2014; 
Horai et al., 2015; Nelson et al., 2015). Most interestingly, 
a newly published study used a human CD8+ T cell clone 
(1E6), which is MHC class I restricted and human prepro-
insulin reactive, to generate high-resolution structures of the 
1E6 TCR bound to seven altered peptide ligands, including 
a microbe-derived peptide (Cole et al., 2016). The authors 
found that this clonal TCR could stably and functionally bind 
with multiple peptide–major histocompatibility complexes 
through a conserved lock-and-key–like minimal binding 
footprint. This enables 1E6 TCR to tolerate vast numbers of 
substitutions outside of these so-called hotspots, which were 
found in foreign antigens compared with the natural auto-
immune ligand, indicating that T cell cross-reactivity with 
microbe-derived antigens could break self-tolerance to in-
duce autoimmune disease. Viral proteins with homology to 
autoantigens have been identified in diabetes. However, there 
is no direct evidence of their diabetogenicity. It is import-
ant to show that not only is this a theoretical possibility, but 
also that the microbial peptides can actually be processed and 
presented appropriately and that there is a direct interaction 
of the bacteria with the autoreactive T cells. Our data clearly 
demonstrated that bacterial lysates as well as the purified 
protein from the L. goodfellowii could be processed by DCs 
and GALT APC and presented the IGRP mimic peptides to 
NY8.3 T cells inducing inflammatory chemokine or cytokine 
MIP-1β, IFN-γ, and TNF production. Most importantly, we 
have shown that after supercolonizing the mice with L. good-
fellowii, the extracted GALT APC stimulated NY8.3 cells in 
the absence of exogenous antigen. This clearly demonstrated 
that not only could the peptide be processed by APC in vitro, 
but also that the L. goodfellowii in the gut could be presented 
to NY8.3 cells in vivo.
Ultimately, however, the question arises as to whether 
these bacteria could have a direct effect on diabetes in vivo, 
as this is a major test of whether these bacteria have physio-
logical and/or immunological relevance. We have shown this 
in several ways. First, immunizing NY8.3 TCR transgenic 
mice with the bacterial mimic peptide accelerated sponta-
neous diabetes, demonstrating the ability of this particular 
peptide to be presented in vivo and activate IGRP reactive 
cells to induce disease. Second, we have shown that disease 
acceleration can occur by increasing L. goodfellowii after su-
sequencing. One- or two-tailed Mann-Whitney test was used for analysis. Data are shown as individual samples. (E) β-Diversity is shown. Assessment of 
the differences in the bacterial composition of the gut microbiota in the mice that were treated either by cohousing or OT (red or green symbols) compared 
with the control mice (blue symbols) is shown by principal component analysis (PCoA). ANO SIM was used for statistical analysis. (F and G) Comparison of 
the abundance of gut bacteria in the control, cohoused, and OT MyD88−/−NY8.3NOD mice is shown by phylum (F) and family (G). Two-way ANO VA was 
performed with Bonferroni correction. (H) Diabetes incidence in the progeny of MyD88−/−NY8.3NOD mice that were protected from diabetes after fecal OT 
(shown in B). (A, B, and G) The data were pooled from at least two independent experiments. (D–G) The results are from one of two independent experiments. 
Data are shown as mean ± SEM. **, P < 0.01; ***, P < 0.001.
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percolonization of the bacteria in the gut, indicating that the 
bacterial proteins and peptides can be presented in vivo to the 
IGRP-reactive T cells in the NY8.3 mice.
The gut microbiota comprises a large number of gen-
era of bacteria that are very sensitive to the environment, 
including influences from diet, water, and antibiotics. Host 
factors including MyD88, a key adaptor for innate immunity, 
are also important (Wen et al., 2008). Identifying commen-
sal gut bacteria that could trigger or increase autoreac-
tive responses will considerably advance our understanding 
of environmental influences in pathogenesis of disease and 
provide important targets for therapy. The increase in Fuso-
bacteria in the MyD88−/−NY8.3NOD mice increases the 
abundance of the bacterial protein peptide that can stimulate 
the NY8.3 T cells. When the gut microbiota composition in 
MyD88−/−NY8.3NOD mice was altered through cohousing 
or fecal transfer, this completely reversed the diabetes acceler-
ation in MyD88−/−NY8.3NOD mice and was associated with 
the reduction of the Fusobacteria. Moreover, L. goodfellowii, 
a strain of Fusobacteria, can directly stimulate IGRP-reactive 
T cells in this pathogenic process. Fusobacteria are normally 
present in low abundance in NOD mice; however, there was 
a strong correlation between the abundance of Fusobacteria 
and progression to diabetes in polyclonal NOD mice. Fur-
thermore, there were also significantly more Fusobacteria 
in diabetic NOD mice compared with the age- and gen-
der-matched nondiabetic NOD littermates. Thus, the expan-
sion of NY8.3-like CD8 T cells correlates with an increase 
in gut Fusobacteria and could conceivably be caused by the 
increase of Fusobacteria. It should be noted that IGRP-reac-
tive T cells are not the only autoreactive CD8 T cells involved 
in the development of diabetes, and there is heterogeneity of 
early abundance of different TCR clonotypes (Lieberman et 
al., 2004). Furthermore, IGRP reactivity is dependent on an 
autoimmune response to insulin (Krishnamurthy et al., 2006, 
2008), but these cells also increase in avidity and abundance 
with time (Amrani et al., 2000). Thus, it is likely, in the poly-
clonal setting, that other factors will also interact to increase 
the abundance of these bacteria or other microbial antigens to 
contribute to the development of diabetes. Fusobacteria have 
been reported to be associated with inflammatory disorders 
including inflammatory bowel diseases (Ohkusa et al., 2003; 
Strauss et al., 2011). Whether Fusobacteria are also associated 
with human T1D development remains to be elucidated.
The increase of Firmicutes and decrease of Bacteroide-
tes are correlated with delay of or protection from diabetes 
development in our current study, which support the findings 
in other animal models and/or human studies (Giongo et al., 
2011; de Goffau et al., 2013; Murri et al., 2013; Wolf et al., 
2014). However, our previous study using non-TCR trans-
genic MyD88−/−NOD mice showed a lower ratio of Firmi-
cutes/Bacteroidetes, suggesting that T cell repertoire may play 
a role in the composition of gut microbiota of the host (Wen et 
al., 2008). It is not clear, at this stage, how the T cell repertoire 
affects the bacterial community and the possible biological 
consequences. However, it is clear that changing gut microbi-
ota will have a significant impact on T1D development.
Our study therefore, provides direct evidence of molec-
ular mimicry of microbial peptides with islet autoantigen and 
a novel mechanism by which the diabetogenicity of CD8+ 
T cells can be regulated by innate immunity and the gut mi-
crobiota in T1D. We believe that these data will be not only 
of great interest to investigators involved in studies of the 
pathogenesis and therapy of T1D, but also will be of general 
importance in providing evidence that molecular mimicry, 
originating in the gut microbiome, can indeed be a causative 
factor in the development of autoimmune disease.
MAT ERI ALS AND MET HODS
Mice
NOD/Caj mice have been maintained at Yale University 
for >25 yr. TLR2−/−NOD, TLR4−/−NOD, TLR9−/−NOD, 
and MyD88−/−NOD mice were generated as previously de-
scribed (Wen et al., 2008; Wong et al., 2008). TLR5−/−NOD 
was generated by backcrossing TLR5−/− C57BL/6 (pro-
vided by R. Flavell, Yale University, New Haven, CT) 
with NOD mice for >12 generations. NY8.3NOD 
mice (The Jackson Laboratory) were bred with TLR or 
MyD88-deficient NOD mice to obtain TLR2−/−NY8.3, 
TLR4−/−NY8.3, TLR5−/−NY8.3, TLR9−/−NY8.3, and 
MyD88−/−NY8.3NOD mice. G9Cα−/−NOD mice were 
generated as reported previously (Wong et al., 2009). All the 
mice were kept in specific pathogen-free conditions in a 12-h 
dark/light cycle and housed in individually ventilated filter 
cages with autoclaved food and bedding. The use of animals 
and all procedures were approved by the Institutional An-
imal Care and Use Committee of Yale University and the 
Home Office, Wales, UK.
Table 1. The origin and sequence of the peptides used in the study
Name of the peptides Protein name Origin Position Peptide sequence
IGRP IGRP Mouse 206–214 VYL KTN VFL
W15944 Mgt L. goodfellowii (gram negative, mainly oral cavity) 267–275 TYLK TNVFT
W15945 glycosyl transferase, group 2 uncultured Flavobacteriia bacterium (gram negative, 
commensal)
303–311 FYLKTSVFL
W15946 hypothetical protein IEM_00289 Bacillus cereus (gram positive, gut flora) 252–260 VYLKVNVFK
W15948 NAD synthetase Enterobacter mori LMG 25706 (gram negative) 32–40 SYL KTNAFL
Bold letters represent the amino acids different from those in the same positions in the control IGRP peptide.
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Figure 7. Microbial peptide mimics can activate NY8.3 CD8+ T cells in vitro and induce diabetes in vivo. (A) NY8.3 CD8+ T cell response to microbial 
peptide mimics shown in proliferation assay by [3H]thymidine incorporation. The experiment was repeated at least four times. (B) Representative FACS plots 
for expression of granzyme B (GzmB) and IFN-γ in NY8.3 CD8+ T cells stimulated with mimic peptides or IGRP206–214 peptide (1 µg/ml). Student’s t test was 
used for statistical analysis to compare individual peptide mimics with IGRP206–214 peptide. Data are representative of four independent experiments. n ≥ 10. 
(C) MHC class I blocking assay. Two-tailed Student’s t test was used for statistical analysis. n = 3/group/experiment, and the experiment was performed three 
times. (D) MHC restriction assay. n = 3/group/experiment, and the experiment was performed twice. Two-way ANO VA with Bonferroni correction was used 
for analysis. (E) Diabetes development induced by NY8.3 CD8+ T cells activated with microbial peptide mimics from two independent experiments. Log-rank 
test for survival was used. (F) CTL activity of CD8+ T cells induced by W15944 peptide. Two-way ANO VA with Bonferroni correction was used for analysis. n = 
4/group/experiment, and the experiment was performed three times. (G) Pathogenic effect of W15944-stimulated NY8.3 CD8+ T cells. Log-rank test for sur-
vival was used for statistical analysis. The results are from two independent experiments (n = 5/group/experiment). (H–J) MyD88−/−NY8.3 and WT NY8.3NOD 
CD8 T cells activated by microbial peptide mimics induced diabetes by adoptive transfer into irradiated NOD mice. The experiments were repeated twice. (H) 
W15946. (I) W15948. (J) W15944. Log-rank test for survival was used for analysis. (K) Incidence of diabetes in WT NY83.NOD mice after immunization with 
mimic peptide from L. goodfellowii. The data were pooled from two independent experiments. Log-rank test for survival was used for analysis. (L) Response 
of insulin-specific G9 T cells to the microbial peptides. (Left) Granzyme B. (Right) IFN-γ. n = 2/group/experiment, and the experiment was performed twice. 
One-way ANO VA was used for statistical analysis. Data are mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; *****, P < 0.00001.
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Antibodies and reagents
All the fluorochrome-conjugated mAbs used in this study 
were purchased from eBioscience or BioLegend unless other-
wise stated. Hybridoma supernatants containing mAbs, used 
for cell purification or stimulation, were generously provided 
by C. Janeway Jr. (Yale University). Magnetic beads conju-
gated with goat anti–mouse IgG, goat anti–mouse IgM, or 
goat anti–rat IgG were purchased from QIA GEN. RPMI 
1640 medium and heat-inactivated FCS were purchased from 
Invitrogen and Gemini, respectively.
Isolation of infiltrated immune cells from islets
The pancreata were removed from 6–7-wk-old 
MyD88−/−NY8.3NOD or WT NY8.3NOD mice and in-
cubated with 10 ml HBSS containing 10 mM Hepes and 
1.5 mg/ml collagenase V (Sigma-Aldrich) at 37°C for 12 
min with vigorous shaking. The digestion was terminated by 
adding 10 ml RPMI 1640 containing 5% FBS, and the su-
pernatant was discarded, followed by two more washes with 
HBSS buffer. The islets were spun down and treated with 
0.25% trypsin–0.02% EDTA at 37°C for 5–10 min. The islets 
were then passed through a syringe with a 27-gauge needle 
to disperse into a cell suspension. After washing with PBS, 
the isolated cells were stained with fluorochrome-conjugated 
mAbs for flow cytometric analysis.
Histology of pancreatic tissues
Pancreatic tissues were fixed with 10% buffered forma-
lin, embedded in paraffin, and sectioned at a thickness of 
5 µm, stained with hematoxylin and eosin, and examined 
under light microscopy.
Diagnosis of diabetes
Mice were screened for glycosuria and confirmed by a blood 
glucose of >250 mg/dl (13.9 mmol/L).
Cohousing
MyD88−/−NY8.3NOD mice or WT NY8.3NOD mice (4 
wk old) were cohoused with an equal number of age- and 
sex-matched NOD mice. All the mice were monitored for 
glycosuria twice weekly, and the experiments were termi-
nated at 20 and 30 wk after birth for MyD88−/−NY8.3NOD 
or WT NY8.3NOD and WT NOD mice, respectively, unless 
the mice developed diabetes.
Bacteria OT
Fecal samples were collected from diabetes-protected 
MyD88−/−NY8.3NOD mice, cohoused with NOD mice 
for >3 mo, and orally fed to the sex-matched 4-wk-old 
MyD88−/−NY8.3NOD mice, two to three times weekly for 
three consecutive weeks. All the mice were monitored for 
glycosuria twice weekly. We randomly selected diabetes-free 
MyD88−/−NY8.3NOD mice (Fig. 6 B) as breeders and ob-
served for diabetes in their progeny, also using the progeny 
from the breeders without OT as controls. In some exper-
iments, NOD mice (1.5–2-mo-old females) were gavaged 
with L. goodfellowii or B. theta (∼109 bacteria/mouse) daily 
for 5 d. APCs from spleens or MLNs, PPs and the GALT were 
used for antigen-presentation assays ex vivo.
Extraction of gut bacterial DNA
Fecal samples from WT NY8.3NOD and MyD88−/− 
NY8.3NOD mice were collected biweekly starting from 
1-mo-old mice and stored at −20°C. Bacterial DNA was ex-
Figure 8. Increased abundance of Fu-
sobacteria is associated with diabetes 
development. (A) Abundance of Fusobac-
teria and L. goodfellowii in WT NY8.3NOD 
and MyD88−/−NY8.3NOD mice. Two-tailed 
Mann-Whitney test (fecal samples) or two-
tailed unpaired Student’s t test with Welch’s 
correction (oral samples) was used. n = 7–16 
mice/group from two independent experi-
ments. Data are mean ± SEM. (B) Abundance 
of Fusobacteria in fecal samples from the con-
trol, cohoused, and OT MyD88−/−NY8.3NOD 
mice. Repeated measures ANO VA with Tukey’s 
posthoc test was used for analysis. (C) Abun-
dance of Fusobacteria in diabetic and nondi-
abetic female NOD mice. Student’s t test was 
used. (D) Bacterial DNA was extracted from 
fecal samples of female NOD mice every two 
weeks from 6 wk old until diabetes onset. Re-
sults from three time points are shown. Re-
peated measures ANO VA with Tukey’s posthoc 
test was used. (B–D) Data were pooled from 
at least two independent experiments. *, P < 
0.05; ***, P < 0.001.
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tracted as previously described (Peng et al., 2014). In brief, the 
fecal samples (∼15–25 mg/mouse) were resuspended in 300 µl 
TE (10 mM Tris and 1 mM EDTA, pH 8) and incubated for 
1 h at 37°C in the presence of 7.5 µl SDS (0.5%) and 3 µl pro-
teinase K (20 mg/ml). One volume of phenol/chloroform/
isoamyl alcohol (25:24:1), 200 µl of 20% SDS, and 0.3 g of 
zirconium/silica beads (0.1 mm; Biospec Inc.) were added, and 
samples were mixed with a Mini-bead-beater (Biospec) for 2 
min. The sample was then mixed with 820 µl phenol/chloro-
form/isoamyl alcohol (25:24:1) and centrifuged, and the aque-
ous layer was collected into a new tube. The bacterial DNA was 
precipitated with 0.6 volume of isopropanol, washed with 70% 
ethanol, air dried, and resuspended in 100 µl of sterile water.
16S rRNA sequencing and microbiota classification
The V4 region of the bacterial 16S ribosomal gene was am-
plified from each DNA sample with barcoded broadly con-
served bacterial primers (Table 2). The PCR products were 
purified with a gel extraction kit (QIA GEN) and quanti-
fied with a spectrophotometer (Nanodrop), and equimolar 
Figure 9. L. goodfellowii can activate NY8.3 CD8+ T cells in vitro, and supercolonization accelerates diabetes in naive young WT NY8.3NOD 
mice in vivo. (A) Expression of IFN-γ (ICC staining) in NY8.3 CD8+ T cells stimulated with the L. goodfellowii lysate. (B) MIP-1β secretion (ELI SA) from NY8.3 
CD8+ T cells stimulated with the translated rMgt protein. (C) MIP-1β secretion (ELI SA) from NY8.3 CD8+ T cells stimulated with the purified truncated rMgt 
protein. (D) Inflammatory cytokine induction (ICC staining) in NY8.3 CD8+ T cells stimulated by APCs pulsed with heat-killed bacteria lysates. (E) MIP-1β 
(ELI SA) and IFN-γ production (ICC staining) of NY8.3 CD8+ T cells stimulated with the APCs from NOD mice supercolonized with L. goodfellowii or control 
B. theta. (F) Secreted IFN-γ (ELI SA) from NY8.3 CD8+ T cells stimulated with APCs from NOD mice supercolonized with L. goodfellowii or control B. theta. (G) 
106 splenocytes from NY8.3 mice were stimulated with different heat-killed bacterial strains. (Left) IFN-γ expression (ICC staining). (Right) IFN-γ secretion 
(ELI SA). One-way ANO VA was used for statistical analysis. n = 2/group/experiment, and the experiment was performed twice. (H) Diabetes incidence in 
NY8.3NOD mice after supercolonization with L. goodfellowii or control B. theta. Log-rank test for survival was used for analysis. The results are combined 
from two independent experiments (n = 5–8/group/experiment). (A–F) Two-tailed Student’s t test was used. n = 3–6/group/experiment from three indepen-
dent experiments. Data are shown as mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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amounts of each sample were pooled and pyrosequenced on 
an Ion Torrent personal genome machine sequencing system 
(Thermo Fisher Scientific). The results were analyzed using 
the QII ME software package (version 1.8) and UPA RSE 
pipeline (version 7.0). After removing the primer sequences, 
the sequences were demultiplexed, quality filtered using QII 
ME, and further quality and chimera filtered in UPA RSE 
pipeline. Operational taxonomic units were picked with 97% 
identity in UPA RSE pipeline. In QII ME, the Greengenes 
reference database was used for taxonomy assignment, which 
was performed at various levels using representative sequences 
of each operational taxonomic unit. β-Diversity was calcu-
lated to compare differences between microbial community 
profiles, and the data are shown as a principal coordinate anal-
ysis. α-Diversity was measured by Shannon evenness or Chao 
richness in the bacterial communities.
Quantitation of Fusobacteria and L. goodfellowii by qPCR
Bacterial DNA was extracted as described in the Extraction 
of gut bacterial DNA section from fecal pellet or oral swab 
samples from 6–7-wk-old MyD88−/−NY8.3NOD and WT 
NY8.3NOD mice. qPCR was performed using a qPCR 
detection system (iQ5; Bio-Rad Laboratories) according to 
the manufacturer’s instructions with the specific primers for 
Fusobacteria or L. goodfellowii’s Mgt (Table 2). The relative 
abundance of these bacteria was determined using the 2−ΔΔCt 
method by normalization with total bacteria.
In another experiment, bacterial DNA was extracted 
from fecal samples of female NOD mice (biweekly from 6 
wk old until diabetic). The abundance of Fusobacteria in the 
selected samples from three time points (no insulitis at −6 
wk, mid-insulitis at −10 wk, and insulitis at >13 wk before 
diabetic) was quantified by qPCR.
Quantitation of intestinal antimicrobial peptides by qPCR
Approximately 3-cm fragments from the ileum of small in-
testine and the area adjacent to the cecum of large intestines 
were obtained from 6–7-wk-old MyD88−/−NY8.3NOD and 
WT NY8.3NOD mice. Total RNA was extracted from the 
gut fragments with TRIzol and reverse transcribed to cDNA 
using a SuperScript III First-strand synthesis kit with random 
hexamers (Invitrogen). qPCR was performed with the spe-
cific primers for Reg3β, Reg3γ, C-reactive protein–ductin, 
RELMβ, and DEF CR-rs-10 (Vaishnava et al., 2008). The rel-
ative mRNA levels of these peptides were determined using 
the 2−ΔΔCt method by normalization with the housekeep-
ing gene GAP DH (Table 2).
Identification and synthesis of mimic peptides
The IGRP206–214 peptide sequence was pBLA ST searched 
against the nonredundant protein sequences database within 
bacterial families, and peptides with high homology were 
identified. The microbial peptide mimics (Table 1) were syn-
thesized and purified with HPLC by the Yale Keck Facility.
Culture of anaerobic bacteria
L. goodfellowii (HM-12; BEI Resources), B. theta (provided 
by A. Goodman and A. Wexler, Yale University, New Haven, 
CT), B. dorei (BEI Resources), and L. reuteri (BEI Re-
sources) were grown in MTGE Anaerobic Enrichment Broth 
(Anaerobe Systems) overnight. For heat-killed bacteria, the 
bacterial pellet was resuspended in sterile 1× PBS and heated 
at 65°C for 60 min. The bacterial lysates were then used to 
stimulate the NY8.3 CD8+ T cells followed by intracellular 
cytokine (ICC) analysis.
Translation of rMgt and expression and purification 
of truncated rMgt protein
The coding region of Mgt (GenPept accession no. 
WP_006806773) from L. goodfellowii was amplified with 
PCR from genomic DNA from L. goodfellowii with spe-
cific primers (Table 2) and then cloned into EcoR I/Xho I 
digested pET23b+ (EMD Millipore). The recombinant vector 
was confirmed with DNA sequencing by the Yale Keck Facil-
ity. The in vitro translation of Mgt was performed in an E. coli 
High-yield Protein Expression System (S30 T7; Promega) ac-
cording to the manufacturer’s instructions. Empty pET23b+ 
was used as a negative control. The truncated rMgt was ex-
Table 2. List of primers
Application Gene name Sequence
Sequencing       16S Forward 5′-GTG CCA GCM GCC GCG GTAA-3′
Reverse 5′-GGA CTA CHV GGG TWT CTA AT-3′
qPCR       Fusobacteria Forward 5′-CCC TTC AGT GCC GCA GT-3′
Reverse 5′-GTC GCA GGA TGT CAA GAC-3′
      Mgt Forward 5′-GGC TTG CCG TAC TTA TGA TTTC-3′
Reverse 5′-TTT AAA GGC ATC TTT GGG AGAA-3′
      16S Forward 5′-ACT CCT ACG GGA GGC AGC AGT-3′
Reverse 5′-ATT ACC GCG GCT GCT GGC-3′
      GAP DH Forward 5′-TGA CAT CAA GAA GGT GGT GAAG-3′
Reverse 5′-TGC TGT AGC CGT ATT CAT TGTC-3′
Cloning       Mgt Forward 5′-ATC CGG AAT TCC ATG AAA GAA ATA ATA GAA ACT CTTA-3′
Reverse 5′-ATC CGC TCG AGA ATT TTC AAA AAC AAT GTA GCA ATT-3′
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pressed and purified by Detai Biologics. In brief, the coding 
region of Mgt was modified by removing two transmem-
brane fragments (355–374 and 382–404) and replacing the 
rare codons for E. coli and cloned into pET43.1a+. The 
recombinant protein was obtained by refolding insoluble 
inclusion bodies and purifying by affinity column chroma-
tography. The single-band purity was confirmed by both 
SDS-PAGE and Western blotting.
Generation of BMDCs, APC isolation, and NY8.3 
CD8+ T cell purification
BMDCs were generated from BM cells of 2-mo-old NOD 
mice. The BM cells were cultured in the presence of 25 ng/
ml GM-CSF and 25 ng/ml IL-4 in RPMI 1640 complete 
medium supplemented with 5% heat-inactivated FBS. Cul-
ture medium was replenished every 2 d. On day 5, adherent 
and loosely adherent cells were harvested. These cells were 
∼70% CD11c+ DCs by FACS analysis.
Peripheral APCs in this study refer to T cell–depleted 
immune cells (CD11c+, CD11b+, and CD19+ cells) and were 
isolated from spleen, MLN, and PP of 2-mo-old female NOD 
mice by depleting CD4+ and CD8+ T cells with hybridoma 
supernatant and magnetic beads.
CD8+ T cells were purified from spleen of 5–8-wk-old 
WT NY8.3NOD or MyD88−/−NY8.3NOD mice by neg-
ative selection with magnetic beads according to the manu-
facturer’s instructions (QIA GEN). The purity was routinely 
90–95% as verified by flow cytometry.
Cell proliferation assay
Splenocytes or purified CD8+ T cells from WT NY8.3NOD 
or MyD88−/−NY8.3NOD mice were cultured in triplicate 
(105 cells/well) in the presence or absence of IGRP206–214 
peptide or bacterial peptide mimics at different concentra-
tions for 4 d. [3H]thymidine was added during the last 18 h 
of a 4-d culture. Proliferation was measured by [3H]thymi-
dine incorporation, and the data are presented as a stimulation 
index, which is the mean cpm in the presence of antigen/the 
mean cpm in the absence of antigen.
MHC blocking assay
Splenocytes from WT NY8.3NOD mice were cultured in 
triplicate (105 cells/well) in the presence or absence of 100 
ng/ml W15944 together with different concentrations of anti- 
Kd (hybridoma supernatant of clone HB159) or control IgG. 
[3H]thymidine was added in the last 16  h of 4-d culture. 
Proliferation was measured by [3H]thymidine incorporation, 
and the data are presented as a stimulation index, which is 
the mean cpm in the presence of antigen/the mean cpm in 
the absence of antigen.
MHC restriction assay
Purified splenic NY8.3 CD8+ T cells were cultured in trip-
licate (105 cells/well) with different concentrations of IGRP 
or W15944 peptide in the presence of irradiated splenic APCs 
from NOD (Kd) or C57BL/6 (Kb) mice. [3H]thymidine was 
added in the last 16 h of 4-d culture. Proliferation was mea-
sured by [3H]thymidine incorporation, and the data are pre-
sented as a stimulation index, which is the mean cpm in the 
presence of antigen/the mean cpm in the absence of antigen.
CTL killing assays
Target P815 cells (104 cells/tube) were labeled with PKH-
26 followed by co-culturing with purified NY8.3 CD8+ T 
cells, as effector cells, from 6–7-wk-old WT NY8.3 mice 
at different ratios in the absence or presence of IGRP or 
W15944 (0.2 µg/ml) in 200 µl at 37°C for 16–18 h. Cells 
were stained with TOP RO-3 iodide before analysis by flow 
cytometry. The cytotoxicity was calculated as the percentage 
of apoptotic cells shown as double positive for TOP RO- 
3 iodide and PKH-26.
Supercolonization of WT NY8.3 mice with B. theta  
or L. goodfellowii
1-mo-old WT NY8.3NOD mice were orally gavaged with 
either B. theta or L. goodfellowii (∼109 bacteria/mouse) daily 
for 30 consecutive days, unless the mice developed diabetes.
ICC, granzyme B, MIP-1β, and IFN-γ secretion assay
ICC staining was performed according to the protocol 
provided by eBioscience. In brief, 1–2 × 106 cells/ml sple-
nocytes from WT NY8.3 or MyD88−/−NY8.3 mice were 
stimulated with anti-CD3 (clone 2C-11) and anti-CD28 
(clone 37N51) antibodies, IGRP206–214, peptide mimics, 
heat-killed bacteria, and APCs either pulsed with heat-killed 
bacteria or directly isolated from bacteria-supercolonized 
NOD mice or rMgt overnight, followed by further stimula-
tion with 50 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml 
ionomycin (Sigma-Aldrich) in the presence of Golgi-plug 
(eBioscience) for an additional 4 h. 106 cells/ml splenocytes 
from G9Cα−/−NOD mice were stimulated with insulin 
B15-23 peptide (G9G) and the bacterial peptide mimics in 
a similar assay. The cells were then stained with antibodies to 
surface markers before fixation and permeabilization. Fc re-
ceptors were blocked with 2.4G2 Fc-blocking antibody be-
fore staining with fluorochrome-labeled antibody to detect 
ICCs or cytolytic protein (IFN-γ and granzyme B). Some 
of the supernatants were used for ELI SA to measure the 
concentration of MIP-1β or IFN-γ.
In some experiments, 1–2 × 105 purified NY8.3 
CD8+ T cells were incubated with 105 cells BMDCs or 1–5 
× 105 APCs, in 300 µl, in the presence of 107 CFU/500 µl 
heat-killed bacterial lysates (L. goodfellowii or B. theta), 
translated Mgt protein (1  µl of the protein lysate; empty 
vector as control), or 1 µg of purified truncated rMgt pro-
tein obtained from E. coli by the pET43.1a+ expression 
vector (carrier protein BSA as control) overnight, followed 
by further stimulation with PMA and ionomycin in the 
presence or absence of Golgi-plug for an additional 4  h. 
The cells were used for ICC staining in the cell culture 
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in the presence of Golgi-plug, and the culture supernatants 
without Golgi-plug were tested for MIP-1β secretion by an 
ELI SA kit (R&D Systems).
To test whether APCs could present antigens from the 
bacteria, 2 × 105 APCs from spleen, MLN, and PP were iso-
lated from 6–8-wk-old naive NOD mice and pulsed with 
heat-killed L. goodfellowii or control B. theta lysates for 3 h 
at 37°C. After washing, the APCs were incubated with 105 
purified NY8.3 CD8+ T cells from WT NY8.3 overnight in 
300 µl, and the cells were stained for use for ICC staining in 
the cell culture in the presence of Golgi-plug.
After supercolonization with the gut bacteria, 105 puri-
fied NY8.3 CD8+ T cells were incubated with purified APCs 
from spleen (106 cells), MLN (3 × 105 cells), or PP (1–2 × 
105 cells) overnight in 300 µl without the addition of exog-
enous antigens. The supernatants before the addition of Gol-
gi-plug were tested for both MIP-1β and IFN-γ secretion 
by ELI SA (R&D Systems), and after 4-h stimulation with 
PMA/ionomycin in the presence of Golgi-plug, the cells 
were used for ICC staining.
Adoptive transfer
Irradiated (600 rads) 1-mo-old NOD mice (both gen-
ders) were used as recipients in adoptive transfer experi-
ments. Splenocytes from 6–7-wk-old WT NY8.3 or 
MyD88−/−NY8.3 mice were stimulated with IGRP206–214 
(10 ng/ml), W15944 (10 ng/ml or 500 ng/ml), or other 
peptide mimics (500 ng/ml) for 3 d at 37°C. 106 activated 
CD8+ T cells, purified with magnetic-activated cell-sort-
ing beads, were i.v. injected into age- and sex-matched 
recipients. Recipients were screened for diabetes develop-
ment by testing for glycosuria daily, and the experiments 
were terminated 20 d after the cell transfer unless the 
mice developed diabetes.
Immunization of mimic peptide in WT NY8.3NOD mice
1-mo-old WT NY8.3NOD mice were i.p. immunized 
once with W15944 or IGRP peptide (25 µg/mouse) to-
gether with CpG (25 µg/mouse) as adjuvant. Control 
mice were injected with CpG (25 µg/mouse) only. Mice 
were screened for glycosuria daily, and the experiments 
were terminated 30 d after immunization unless the 
mice developed diabetes.
Statistical analysis
Statistical analysis was performed using Prism 6 (GraphPad 
Software). Diabetes incidence was compared using Wil-
coxon or log-rank tests. Insulitis was analyzed by χ2 test. In 
vitro assays were analyzed with two-tailed Student’s t test 
or one- or two-tailed Mann Whitney test for statistical sig-
nificance. Analysis of similarities (ANO SIM) was used to 
analyze β-diversity of taxonomic families of gut microbi-
ota. For multiple comparisons, one-way or two-way ANO 
VA followed by Bonferroni test or Tukey’s posthoc test was 
performed. P-values <0.05 were considered significant.
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